MedDataX Logo

Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease

NCT ID: NCT02060877

Last Updated: 2016-10-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to gain insight in the distress experience and quality of life of patients suspected of having a serious lung disease during the diagnostic phase and the period between diagnosis and start of treatment

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A life-threatening disease often leads to distress, an emotional experience that can interfere with coping. Studies in lung cancer patients show high prevalence of distress during the course of the disease. However until now, very few research was done during the diagnostic workup. This prospective study will describe and explore distress, quality of life and illness perception in lung cancer patients during the diagnostic period until first follow-up visit 4 weeks after start of therapy. Patient reported questionnaires will be used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suspected Lung Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

suspected lung cancer diagnostic work-up

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients suspected of having lung cancer

observational study, there is no study intervention, only patient questionnaires

observational study: use of patient questionnaires

Intervention Type OTHER

observational study, there is no study intervention, only patient questionnaires

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observational study: use of patient questionnaires

observational study, there is no study intervention, only patient questionnaires

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ambulatory patient
* imaging suggestive of lung cancer
* written informed consent
* able to complete questionnaires

Exclusion Criteria

* solitary pulmonary nodule
* previous diagnosis of cancer
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

End-of-Life Research Group

OTHER

Sponsor Role collaborator

Universiteit Antwerpen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kathleen Belien

Study Coordinator Thoracale Oncologie Groep Antwerpen

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Van Royen

Role: PRINCIPAL_INVESTIGATOR

Universiteit Antwerpen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Algemeen Stedelijk Ziekenhuis Aalst

Aalst, , Belgium

Site Status

AZ Monica

Antwerp, , Belgium

Site Status

Gasthuis Zusters Antwerpen

Antwerp, , Belgium

Site Status

Universiteit Antwerpen

Antwerp, , Belgium

Site Status

Ziekenhuis Netwerk Antwerpen

Antwerp, , Belgium

Site Status

AZ St Jozef

Bornem, , Belgium

Site Status

AZ Maria Middelares Sint Jozef

Ghent, , Belgium

Site Status

AZ Herentals

Herentals, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B300201419606

Identifier Type: REGISTRY

Identifier Source: secondary_id

TOGA-2013

Identifier Type: -

Identifier Source: org_study_id